Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
NCT00250016 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-12-14
Summary
The purpose of this study is to determine the amount of Aerosolized Liposomal-Nitro-20 (S)-Camptothecin (L9NC) in a patients blood and tumor.
Conditions
- Corpus Uteri
- Endometrial Cancer
Sponsors & Collaborators
-
University of New Mexico
lead OTHER
Principal Investigators
-
Claire F Verschraegen, MD · University of New Mexico
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-31
- Primary Completion
- 2007-04-30
- Completion
- 2007-08-31
Countries
- United States
Study Locations
More Related Trials
-
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
NCT06414434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors
NCT00879905 ·Status: COMPLETED ·Phase: PHASE1
-
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
NCT04795713 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors
NCT06681870 ·Status: WITHDRAWN ·Phase: PHASE1
-
Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
NCT05043649 ·Status: TERMINATED ·Phase: PHASE1
-
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
NCT02517398 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
NCT02298387 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors
NCT01251562 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Mitoxantrone Hydrochloride Liposome Injection
NCT02131688 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
NCT00921336 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
NCT00329004 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens
NCT01009190 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma
NCT04900766 ·Status: TERMINATED ·Phase: PHASE1
-
Study of NMS-1116354 in Solid Tumors
NCT01016327 ·Status: TERMINATED ·Phase: PHASE1
-
SMP-3124LP in Adults With Advanced Solid Tumors
NCT06526819 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
NCT00947739 ·Status: COMPLETED ·Phase: PHASE1
-
Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
NCT02503709 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
NCT02503423 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
NCT05821777 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
NCT03422679 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy
NCT02925000 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
NCT04260802 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
NCT02243917 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT07006727 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors
NCT06992713 ·Status: RECRUITING ·Phase: PHASE1